Arthritis Clinical Trials in Los Angeles, CA

53 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis	Phase 2	Avalyn Pharma Inc.	<1 mi
Innovations in Genicular Outcomes Registry	—	Pacira Pharmaceuticals, Inc	<1 mi
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.	Phase 2	Artiva Biotherapeutics, Inc.	<1 mi
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)	Phase 1	AbbVie	<1 mi
The Myelin Disorders Biorepository Project	—	Children's Hospital of Philadelphia	<1 mi
Biologic Therapy to Prevent Osteoarthritis After ACL Injury	Early 1	University of California, Los Angeles	<1 mi
MDR - Comprehensive Primary Revision Stems PMCF	—	Zimmer Biomet	<1 mi
RA-PRO PRAGMATIC TRIAL	Phase 3	University of Alabama at Birmingham	<1 mi
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare	Phase 2/3	Olatec Therapeutics LLC	<1 mi
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry	—	Duke University	<1 mi
A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression	Early 1	University of California, Los Angeles	<1 mi
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis	Phase 2	AbbVie	9 mi
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Knee Osteoarthritis	Early 1	R3 Medical Research	9 mi
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar Pain	Phase 1	R3 Stem Cell	9 mi
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease	Phase 3	Vor Biopharma	9 mi
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)	Phase 4	Eli Lilly and Company	13 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines	Phase 3	Takeda	13 mi
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults	Phase 1	UCB Biopharma SRL	13 mi
A Study of SPY072 in Rheumatic Disease	Phase 2	Spyre Therapeutics, Inc.	13 mi
Study of GS-0151 in Participants With Rheumatoid Arthritis	Phase 1	Gilead Sciences	13 mi
ConsideRAte Study - Splenic Stimulation for RA	N/A	Galvani Bioelectronics	13 mi
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease	—	TScan Therapeutics, Inc.	14 mi
A Study of Dotinurad Versus Allopurinol in Participants With Gout	Phase 3	Crystalys Therapeutics	14 mi
Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)	Phase 2	Merck Sharp & Dohme LLC	14 mi
A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis	Phase 2/3	Nature Cell Co. Ltd.	14 mi
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)	Phase 1	UCB Biopharma SRL	14 mi
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis	Phase 3	Medipost, Inc.	14 mi
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response	Phase 3	MoonLake Immunotherapeutics AG	14 mi
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout	Phase 4	Massachusetts General Hospital	14 mi
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.	Phase 3	Paradigm Biopharmaceuticals Ltd.	17 mi
A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)	Phase 2	Merck Sharp & Dohme LLC	18 mi
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)	Phase 3	Amgen	20 mi
At-home Ultrasound Localized Therapy for Rheumatoid Arthritis Study [At-home ULTRA Study]	N/A	SecondWave Systems Inc.	20 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines	Phase 3	Takeda	20 mi
A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants	Phase 2	Crystalys Therapeutics	22 mi
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants	Phase 1	AstraZeneca	22 mi
A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients	Phase 3	Doron Therapeutics Inc.	25 mi
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis	Phase 2	AstraZeneca	25 mi
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)	Phase 1/2	Nkarta, Inc.	29 mi
Primary Subtalar Arthrodesis for Calcaneal Fractures	N/A	Wake Forest University Health Sciences	29 mi
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight	Phase 3	Eli Lilly and Company	29 mi
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis	Phase 3	Takeda	29 mi
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee	Phase 3	Eli Lilly and Company	31 mi
Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis	Phase 2	AbbVie	31 mi
A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis	Phase 2	Janssen Research & Development, LLC	31 mi
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)	Phase 2	Elevara Medicines Limited	32 mi
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)	Phase 2	Hoffmann-La Roche	34 mi
Adipose-Derived Biocellular Regenerative Therapy for Osteoarthritis	N/A	Healeon Medical Inc	34 mi
Zimmer Biomet Shoulder Arthroplasty PMCF	N/A	Zimmer Biomet	36 mi
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain	Phase 2	Eli Lilly and Company	36 mi
Exactech Shoulder Post Market Clinical Follow-up Study	—	Exactech	43 mi
A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis	Phase 3	Bristol-Myers Squibb	45 mi
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain	Phase 3	Novo Nordisk A/S	45 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.